• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合基因组分析确定 11p 染色体缺失对侵袭性垂体催乳素瘤转录组活性的影响。

Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.

机构信息

INSERM, U842, Lyon, France.

出版信息

Brain Pathol. 2011 Sep;21(5):533-43. doi: 10.1111/j.1750-3639.2011.00476.x. Epub 2011 Feb 23.

DOI:10.1111/j.1750-3639.2011.00476.x
PMID:21251114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8094244/
Abstract

Integrative genomics approaches associating DNA structure and transcriptomic analysis should allow the identification of cascades of events relating to tumor aggressiveness. While different genome alterations have been identified in pituitary tumors, none have ever been correlated with the aggressiveness. This study focused on one subtype of pituitary tumor, the prolactin (PRL) pituitary tumors, to identify molecular events associated with the aggressive and malignant phenotypes. We combined a comparative genomic hybridization and transcriptomic analysis of 13 PRL tumors classified as nonaggressive or aggressive. Allelic loss within the p arm region of chromosome 11 was detected in five of the aggressive tumors. Allelic loss in the 11q arm was observed in three of these five tumors, all three of which were considered as malignant based on the occurrence of metastases. Comparison of genomic and transcriptomic data showed that allelic loss impacted upon the expression of genes located in the imbalanced region. Data filtering allowed us to highlight five deregulated genes (DGKZ, CD44, TSG101, GTF2H1, HTATIP2), within the missing 11p region, potentially responsible for triggering the aggressive and malignant phenotypes of PRL tumors. Our combined genomic and transcriptomic analysis underlines the importance of chromosome allelic loss in determining the aggressiveness and malignancy of tumors.

摘要

综合基因组学方法将 DNA 结构与转录组分析相结合,应该能够鉴定与肿瘤侵袭性相关的级联事件。虽然已经在垂体肿瘤中鉴定出了不同的基因组改变,但没有一种与侵袭性相关。本研究集中在垂体肿瘤的一种亚型,即催乳素(PRL)垂体肿瘤,以鉴定与侵袭性和恶性表型相关的分子事件。我们对 13 例被归类为非侵袭性或侵袭性的 PRL 肿瘤进行了比较基因组杂交和转录组分析。在 5 例侵袭性肿瘤中检测到 11 号染色体 p 臂区域的等位基因丢失。在这 5 例肿瘤中有 3 例观察到 11q 臂的等位基因丢失,所有这 3 例均根据转移的发生被认为是恶性的。基因组和转录组数据的比较表明,等位基因丢失影响位于不平衡区域的基因的表达。数据筛选使我们能够突出 5 个失调基因(DGKZ、CD44、TSG101、GTF2H1、HTATIP2),这些基因位于缺失的 11p 区域内,可能导致 PRL 肿瘤的侵袭性和恶性表型。我们的综合基因组学和转录组学分析强调了染色体等位基因丢失在决定肿瘤侵袭性和恶性程度方面的重要性。

相似文献

1
Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.综合基因组分析确定 11p 染色体缺失对侵袭性垂体催乳素瘤转录组活性的影响。
Brain Pathol. 2011 Sep;21(5):533-43. doi: 10.1111/j.1750-3639.2011.00476.x. Epub 2011 Feb 23.
2
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors.用于催乳素垂体瘤侵袭、增殖和侵袭性的诊断标志物集。
Endocr Relat Cancer. 2007 Sep;14(3):887-900. doi: 10.1677/ERC-07-0062.
3
Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.垂体腺瘤的基因组和转录组分析揭示了拷贝数变异对泌乳素分泌型亚型中基因表达和临床预后的影响。
Aging (Albany NY). 2020 Dec 19;13(1):1276-1293. doi: 10.18632/aging.202304.
4
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.染色体不稳定性在垂体神经内分泌肿瘤预后预测中的作用。
Acta Neuropathol Commun. 2020 Nov 10;8(1):190. doi: 10.1186/s40478-020-01067-5.
5
Molecular screening of pituitary adenomas for gene mutations and rearrangements.垂体腺瘤的基因突变和重排的分子筛查。
J Clin Endocrinol Metab. 1993 Jul;77(1):50-5. doi: 10.1210/jcem.77.1.8100831.
6
Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?染色体区域7q和11p的扩增在神经母细胞瘤中是重要的异常情况吗?
Cancer Genet Cytogenet. 2003 Jan 15;140(2):133-7. doi: 10.1016/s0165-4608(02)00681-7.
7
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors.miR-183 和 KIAA0101 在侵袭性和恶性垂体肿瘤中的失调。
Front Med (Lausanne). 2015 Aug 10;2:54. doi: 10.3389/fmed.2015.00054. eCollection 2015.
8
[Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].[褪黑素通过抑制大鼠PRL基因增强子元件突变抑制垂体催乳素分泌瘤的增殖]
Sheng Li Xue Bao. 2005 Jun 25;57(3):319-27.
9
Comparative genomic hybridization analysis of nonfunctioning pituitary tumors.无功能垂体瘤的比较基因组杂交分析
J Clin Endocrinol Metab. 1998 May;83(5):1801-5. doi: 10.1210/jcem.83.5.4818.
10
[Homeoproteins and pituitary adenoma].[同源异形蛋白与垂体腺瘤]
Ann Endocrinol (Paris). 1997;58(1):3-10.

引用本文的文献

1
Identification of potential shared core biomarkers in type 2 diabetes and sarcopenia.2型糖尿病与肌肉减少症潜在共享核心生物标志物的鉴定
Sci Rep. 2025 Jul 15;15(1):25439. doi: 10.1038/s41598-025-10200-0.
2
A Brief Overview of Molecular Biology in Pituitary Adenomas with a Focus on Aggressive Lesions.垂体腺瘤分子生物学概述:聚焦侵袭性病变
Int J Mol Sci. 2025 Apr 15;26(8):3717. doi: 10.3390/ijms26083717.
3
Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors.单细胞转录组分析揭示了垂体神经内分泌肿瘤的肿瘤细胞异质性和免疫微环境特征。
Genome Med. 2024 Jan 2;16(1):2. doi: 10.1186/s13073-023-01267-3.
4
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.帕唑帕尼的治疗反应:泌乳素瘤侵袭性的分子异常的病例报告及文献复习。
Front Endocrinol (Lausanne). 2023 Jul 17;14:1195792. doi: 10.3389/fendo.2023.1195792. eCollection 2023.
5
Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment.侵袭性垂体肿瘤和垂体癌:从病理学到治疗。
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1585-1601. doi: 10.1210/clinem/dgad098.
6
The hallmarks of cancer… in pituitary tumors?癌症的特征……在垂体肿瘤中?
Rev Endocr Metab Disord. 2023 Apr;24(2):177-190. doi: 10.1007/s11154-022-09777-y. Epub 2022 Dec 31.
7
Pituitary carcinoma - case series and review of the literature.垂体癌 - 病例系列和文献复习。
Front Endocrinol (Lausanne). 2022 Sep 8;13:968692. doi: 10.3389/fendo.2022.968692. eCollection 2022.
8
MicroRNAs as Potential Biomarkers in Pituitary Adenomas.微小RNA作为垂体腺瘤潜在的生物标志物
Noncoding RNA. 2021 Sep 3;7(3):55. doi: 10.3390/ncrna7030055.
9
Aggressive pituitary tumours and pituitary carcinomas.侵袭性垂体肿瘤和垂体癌。
Nat Rev Endocrinol. 2021 Nov;17(11):671-684. doi: 10.1038/s41574-021-00550-w. Epub 2021 Sep 7.
10
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.染色体不稳定性在垂体神经内分泌肿瘤预后预测中的作用。
Acta Neuropathol Commun. 2020 Nov 10;8(1):190. doi: 10.1186/s40478-020-01067-5.

本文引用的文献

1
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.一种用于识别癌症中异常基因和通路的综合多维度遗传和表观遗传策略。
BMC Syst Biol. 2010 May 17;4:67. doi: 10.1186/1752-0509-4-67.
2
AIP gene and familial isolated pituitary adenomas.AIP 基因与家族性孤立性垂体腺瘤。
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):71-9. doi: 10.1016/j.mce.2010.05.001. Epub 2010 May 8.
3
Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach.人类垂体肿瘤的增殖标志物:全基因组转录组方法的贡献。
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):30-9. doi: 10.1016/j.mce.2010.02.043. Epub 2010 Mar 6.
4
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.泌乳素垂体瘤的预后因素:来自 94 例长期术后随访患者的临床、组织学和分子数据。
J Clin Endocrinol Metab. 2010 Apr;95(4):1708-16. doi: 10.1210/jc.2009-1191. Epub 2010 Feb 17.
5
Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.整合基因组分析确定了 11q 染色体缺失的神经母细胞瘤中具有不同结局的两种不同分子亚型。
Oncogene. 2010 Feb 11;29(6):865-75. doi: 10.1038/onc.2009.390. Epub 2009 Nov 9.
6
Genome-wide DNA methylation profiles in precancerous conditions and cancers.癌前状态和癌症中的全基因组 DNA 甲基化谱。
Cancer Sci. 2010 Jan;101(1):36-45. doi: 10.1111/j.1349-7006.2009.01383.x. Epub 2009 Oct 1.
7
The pathogenesis of pituitary tumors.垂体肿瘤的发病机制。
Annu Rev Pathol. 2009;4:97-126. doi: 10.1146/annurev.pathol.4.110807.092259.
8
Decreased TIP30 expression promotes tumor metastasis in lung cancer.TIP30表达降低促进肺癌肿瘤转移。
Am J Pathol. 2009 May;174(5):1931-9. doi: 10.2353/ajpath.2009.080846. Epub 2009 Apr 6.
9
Segmental copy number variation shapes tissue transcriptomes.节段性拷贝数变异塑造组织转录组。
Nat Genet. 2009 Apr;41(4):424-9. doi: 10.1038/ng.345. Epub 2009 Mar 8.
10
Diacylglycerol kinase zeta is associated with chromatin, but dissociates from condensed chromatin during mitotic phase in NIH3T3 cells.二酰甘油激酶ζ与染色质相关,但在NIH3T3细胞的有丝分裂期从浓缩染色质上解离。
J Cell Biochem. 2008 Oct 15;105(3):756-65. doi: 10.1002/jcb.21873.